Placenta previa and maternal hemorrhagic morbidity

Karen Gibbins, Brett D. Einerson, Michael W. Varner, Robert M. Silver

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objective: Placenta previa is associated with maternal hemorrhage, but most literature focuses on morbidity in the setting of placenta accreta. We aim to characterize maternal morbidity associated with previa and to define risk factors for hemorrhage. Methods: This is a secondary cohort analysis of the NICHD Maternal–Fetal Medicine Units Network Cesarean Section Registry. This analysis included all women undergoing primary Cesarean delivery without placenta accreta. About 496 women with previa were compared with 24,201 women without previa. Primary outcome was composite maternal hemorrhagic morbidity. Non-hemorrhagic morbidities and risk factors for hemorrhage were also evaluated. Results: Maternal hemorrhagic morbidity was more common in women with previa (19 versus 7%, aRR 2.6, 95% CI 1.9–3.5). Atony requiring uterotonics (aRR 3.1, 95% CI 2.0–4.9), red blood cell transfusion (aRR 3.8, 95% CI 2.5–5.7), and hysterectomy (aRR 5.1, 95% CI 1.5–17.3) were also more common with previa. For women with previa, factors associated with maternal hemorrhage were pre-delivery anemia, thrombocytopenia, diabetes, magnesium use, and general anesthesia. Conclusion: Placenta previa is an independent risk factor for maternal hemorrhagic morbidity. Some risk factors are modifiable, but many are intrinsic to the clinical scenario.

Original languageEnglish (US)
Pages (from-to)494-499
Number of pages6
JournalJournal of Maternal-Fetal and Neonatal Medicine
Volume31
Issue number4
DOIs
StatePublished - Feb 16 2018
Externally publishedYes

Fingerprint

Placenta Previa
Mothers
Morbidity
Placenta Accreta
Hemorrhage
National Institute of Child Health and Human Development (U.S.)
Erythrocyte Transfusion
Hysterectomy
Cesarean Section
Thrombocytopenia
General Anesthesia
Magnesium
Registries
Anemia
Cohort Studies
Medicine

Keywords

  • maternal morbidity
  • obstetric hemorrhage
  • Placenta previa

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

Placenta previa and maternal hemorrhagic morbidity. / Gibbins, Karen; Einerson, Brett D.; Varner, Michael W.; Silver, Robert M.

In: Journal of Maternal-Fetal and Neonatal Medicine, Vol. 31, No. 4, 16.02.2018, p. 494-499.

Research output: Contribution to journalArticle

Gibbins, Karen ; Einerson, Brett D. ; Varner, Michael W. ; Silver, Robert M. / Placenta previa and maternal hemorrhagic morbidity. In: Journal of Maternal-Fetal and Neonatal Medicine. 2018 ; Vol. 31, No. 4. pp. 494-499.
@article{76aa19352e144896863cdfb17320f74e,
title = "Placenta previa and maternal hemorrhagic morbidity",
abstract = "Objective: Placenta previa is associated with maternal hemorrhage, but most literature focuses on morbidity in the setting of placenta accreta. We aim to characterize maternal morbidity associated with previa and to define risk factors for hemorrhage. Methods: This is a secondary cohort analysis of the NICHD Maternal–Fetal Medicine Units Network Cesarean Section Registry. This analysis included all women undergoing primary Cesarean delivery without placenta accreta. About 496 women with previa were compared with 24,201 women without previa. Primary outcome was composite maternal hemorrhagic morbidity. Non-hemorrhagic morbidities and risk factors for hemorrhage were also evaluated. Results: Maternal hemorrhagic morbidity was more common in women with previa (19 versus 7{\%}, aRR 2.6, 95{\%} CI 1.9–3.5). Atony requiring uterotonics (aRR 3.1, 95{\%} CI 2.0–4.9), red blood cell transfusion (aRR 3.8, 95{\%} CI 2.5–5.7), and hysterectomy (aRR 5.1, 95{\%} CI 1.5–17.3) were also more common with previa. For women with previa, factors associated with maternal hemorrhage were pre-delivery anemia, thrombocytopenia, diabetes, magnesium use, and general anesthesia. Conclusion: Placenta previa is an independent risk factor for maternal hemorrhagic morbidity. Some risk factors are modifiable, but many are intrinsic to the clinical scenario.",
keywords = "maternal morbidity, obstetric hemorrhage, Placenta previa",
author = "Karen Gibbins and Einerson, {Brett D.} and Varner, {Michael W.} and Silver, {Robert M.}",
year = "2018",
month = "2",
day = "16",
doi = "10.1080/14767058.2017.1289163",
language = "English (US)",
volume = "31",
pages = "494--499",
journal = "Journal of Maternal-Fetal and Neonatal Medicine",
issn = "1476-7058",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Placenta previa and maternal hemorrhagic morbidity

AU - Gibbins, Karen

AU - Einerson, Brett D.

AU - Varner, Michael W.

AU - Silver, Robert M.

PY - 2018/2/16

Y1 - 2018/2/16

N2 - Objective: Placenta previa is associated with maternal hemorrhage, but most literature focuses on morbidity in the setting of placenta accreta. We aim to characterize maternal morbidity associated with previa and to define risk factors for hemorrhage. Methods: This is a secondary cohort analysis of the NICHD Maternal–Fetal Medicine Units Network Cesarean Section Registry. This analysis included all women undergoing primary Cesarean delivery without placenta accreta. About 496 women with previa were compared with 24,201 women without previa. Primary outcome was composite maternal hemorrhagic morbidity. Non-hemorrhagic morbidities and risk factors for hemorrhage were also evaluated. Results: Maternal hemorrhagic morbidity was more common in women with previa (19 versus 7%, aRR 2.6, 95% CI 1.9–3.5). Atony requiring uterotonics (aRR 3.1, 95% CI 2.0–4.9), red blood cell transfusion (aRR 3.8, 95% CI 2.5–5.7), and hysterectomy (aRR 5.1, 95% CI 1.5–17.3) were also more common with previa. For women with previa, factors associated with maternal hemorrhage were pre-delivery anemia, thrombocytopenia, diabetes, magnesium use, and general anesthesia. Conclusion: Placenta previa is an independent risk factor for maternal hemorrhagic morbidity. Some risk factors are modifiable, but many are intrinsic to the clinical scenario.

AB - Objective: Placenta previa is associated with maternal hemorrhage, but most literature focuses on morbidity in the setting of placenta accreta. We aim to characterize maternal morbidity associated with previa and to define risk factors for hemorrhage. Methods: This is a secondary cohort analysis of the NICHD Maternal–Fetal Medicine Units Network Cesarean Section Registry. This analysis included all women undergoing primary Cesarean delivery without placenta accreta. About 496 women with previa were compared with 24,201 women without previa. Primary outcome was composite maternal hemorrhagic morbidity. Non-hemorrhagic morbidities and risk factors for hemorrhage were also evaluated. Results: Maternal hemorrhagic morbidity was more common in women with previa (19 versus 7%, aRR 2.6, 95% CI 1.9–3.5). Atony requiring uterotonics (aRR 3.1, 95% CI 2.0–4.9), red blood cell transfusion (aRR 3.8, 95% CI 2.5–5.7), and hysterectomy (aRR 5.1, 95% CI 1.5–17.3) were also more common with previa. For women with previa, factors associated with maternal hemorrhage were pre-delivery anemia, thrombocytopenia, diabetes, magnesium use, and general anesthesia. Conclusion: Placenta previa is an independent risk factor for maternal hemorrhagic morbidity. Some risk factors are modifiable, but many are intrinsic to the clinical scenario.

KW - maternal morbidity

KW - obstetric hemorrhage

KW - Placenta previa

UR - http://www.scopus.com/inward/record.url?scp=85013460577&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013460577&partnerID=8YFLogxK

U2 - 10.1080/14767058.2017.1289163

DO - 10.1080/14767058.2017.1289163

M3 - Article

C2 - 28140723

AN - SCOPUS:85013460577

VL - 31

SP - 494

EP - 499

JO - Journal of Maternal-Fetal and Neonatal Medicine

JF - Journal of Maternal-Fetal and Neonatal Medicine

SN - 1476-7058

IS - 4

ER -